Search research articles
Contact Us
Filters
Showing results (101-110 of 111) with videos related to
Page
of 12
Sort By:
Geburtshilfe Und Frauenheilkunde
|
October 7, 2014
Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference
M Hubalek, R Bartsch, M Gnant, et al.
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
ESMO Open
|
April 1, 2026
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
N Dobrić, S O Hasenleithner, C Suppan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
R Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
M Gnant, M Filipits, R Greil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M Gnant, B Mlineritsch, H Stoeger, et al.
Epidemiology and Psychiatric Sciences
|
October 17, 2022
Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study
E L Zeilinger, C Oppenauer, M Knefel, et al.
ESMO Open
|
January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
R Bartsch, J M Pérez-García, J Furtner, et al.
ESMO Open
|
December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group
S P Gampenrieder, V Dezentjé, M Lambertini, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 111) with videos related to
Sort By:
Page
of 12
Geburtshilfe Und Frauenheilkunde
|
October 7, 2014
Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference
M Hubalek, R Bartsch, M Gnant, et al.
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
ESMO Open
|
April 1, 2026
Integrating baseline ctDNA-derived tumor metrics enhances risk stratification in HR-positive/HER2-negative advanced breast cancer: a real-world multicenter cohort study from Austria
N Dobrić, S O Hasenleithner, C Suppan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry
R Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)
G G Steger, R Greil, A Lang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2013
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
M Gnant, M Filipits, R Greil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M Gnant, B Mlineritsch, H Stoeger, et al.
Epidemiology and Psychiatric Sciences
|
October 17, 2022
Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study
E L Zeilinger, C Oppenauer, M Knefel, et al.
ESMO Open
|
January 4, 2025
Results of a patient-level pooled analysis of three studies of trastuzumab deruxtecan in HER2-positive breast cancer with active brain metastasis
R Bartsch, J M Pérez-García, J Furtner, et al.
ESMO Open
|
December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group
S P Gampenrieder, V Dezentjé, M Lambertini, et al.
Page
of 12